Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
ConclusionUse of PPIs during CDI treatment in elderly patients is associated with decreased 180-day mortality. Although use of PPIs has been associated with an increased risk of CDI, it appears to be protective against mortality when used during the treatment phase.
Source: Gut Pathogens - Category: Microbiology Source Type: research
More News: Academia | Clostridium Difficile | Health Management | Microbiology | Proton Pump Inhibitors PPIs | Study